Clinical Trial Update: Use of a Microbial Sealant to Reduce Surgical Site Infections. [Phase 4]

View source ↗

Summary

Phase 4 trial completed evaluating a microbial sealant to reduce surgical site infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Surgical Site Infection

Drugs mentioned

• Microbial Sealant

Snippet

Sponsor: University of Southern California | Conditions: Surgical Site Infection, SCIP | Phase 4 | Status: COMPLETED